Ayyasolla v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided February 7, 2022·No. 16-989·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 16-989V (Not to be Published)

************************* KAMESHWAR RAO S. AYYASOLLA, * * Chief Special Master Corcoran Petitioner, * * Dated: January 11, 2022 v. * * * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * * *************************

Robert J. Krakow, Law Office of Robert Krakow, P.C., New York, NY, for Petitioner.

Nina Ren, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION GRANTING IN PART INTERIM AWARD OF ATTORNEY’S FEES AND COSTS 1

On August 11, 2016, Kameshwar Rao S. Ayyasolla filed a petition seeking compensation under the National Vaccine Injury Compensation Program (“Vaccine Program”). 2 Petitioner alleged that he had experienced Guillain Barré syndrome (“GBS”) due to the administration of the

1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the Court of Federal Claims’s website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012)). This means that the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa- 12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). Tetanus Diptheria acellular-Pertussis (“TDaP”) vaccine on August 12, 2013. Petition at 1 (ECF No. 1). The matter is still pending and undecided.

Petitioner has now filed a motion for an interim award of attorney’s fees and costs—the first request for fees since the case was initiated. Motion, dated Nov. 2, 2021 (ECF No. 91) (“Interim Fees Mot.”). Petitioner specifically requests $130,349.50 in fees for the work of his attorney, Mr. Robert Krakow, and paralegals. Id. at 4, 12. Work began on this matter about five and a half years ago, and the billing invoices cover from before the claim’s filing to November 2, 2021 (when the interim fees request was filed). Petitioner also seeks $32,161.68 for costs, largely including expert report preparation. Id. at 4. Respondent reacted to the interim fees request on November 3, 2021. See Response, dated Nov. 3, 2021 (ECF No. 92) (“Response”). Respondent requests I apply discretion in determining whether this case was filed and proceeded with a reasonable basis, and also exercise my discretion in the amount of any fees award. Id. at 3. Petitioner replied the same day as Respondent’s reactive brief, relying on arguments set forth in his previous motion. Reply, dated Nov. 3, 2021 (ECF No. 93) (“Reply”).

For the reasons set forth below, I hereby GRANT Petitioner’s motion in part, awarding fees and costs in the total amount of $83,036.93 reflecting $65,174.75 in attorney’s fees and $17,862.18 in costs. I defer resolution of the unawarded portions of fees and costs (the latter of which are solely expert costs) to the end of the proceeding, for the reasons set forth below.

ANALYSIS

I. Petitioner’s Claim Has Reasonable Basis At Present

Although the Vaccine Act only guarantees a reasonable award of attorney’s fees and costs to successful petitioners, a special master may also award fees and costs in an unsuccessful case if: (1) the “petition was brought in good faith”; and (2) “there was a reasonable basis for the claim for which the petition was brought.” Section 15(e)(1). I have in prior decisions set forth at length the criteria to be applied when determining if a claim possessed “reasonable basis” sufficient for a fees award. See, e.g., Sterling v. Sec’y of Health & Hum. Servs., No. 16-551V, 2020 WL 549443, at *4 (Fed. Cl. Spec. Mstr. Jan. 3, 2020). Importantly, reasonable basis is only a threshold requirement in unsuccessful cases; the fact that a petitioner can meet the fairly-light evidentiary requirement to show reasonable basis does not obligate a special master to award fees, and the calculation of the sum to be awarded is otherwise subject to the same reasonableness standards governing all fees determinations.

A claim’s reasonable basis must be demonstrated through some objective evidentiary showing. Cottingham v. Sec’y of Health & Hum. Servs., 971 F.3d 1337, 1344 (Fed. Cir. 2020) (citing Simmons v. Sec’y of Health & Hum. Servs., 875 F.3d 632, 635 (Fed. Cir. 2017)). This objective inquiry is focused on the claim itself—counsel’s conduct in prosecuting the claim is irrelevant (although it may bulwark good faith). Simmons, 875 F.3d at 635. Reasonable basis inquiries are not static—they evaluate not only what was known at the time the petition was filed, but also take into account what was learned about the evidentiary support for the claim as the matter progressed. Perreira v. Sec’y of Health & Hum. Servs., 33 F.3d 1375, 1377 (Fed. Cir. 1994) (upholding the finding that a reasonable basis for petitioners’ claims ceased to exist once they had reviewed their expert's opinion, which consisted entirely of unsupported speculation).

The standard for reasonable basis is lesser (and thus inherently easier to satisfy) than the preponderant standard applied when assessing entitlement, as cases that fail can still have sufficient objective grounding for a fees award. Braun v. Sec’y of Health & Hum. Servs., 144 Fed. Cl. 72, 77 (2019). The Court of Federal Claims has affirmed that “[r]easonable basis is a standard that petitioners, at least generally, meet by submitting evidence.” Chuisano v. Sec’y of Health & Hum. Servs., 116 Fed. Cl. 276, 287 (Fed. Cl. 2014) (internal quotations omitted) (affirming special master). The factual basis and medical support for the claim is among the evidence that should be considered. Carter v. Sec’y of Health & Hum. Servs., 132 Fed. Cl. 372, 378 (Fed. Cl. 2017). Under the Vaccine Act, special masters have “maximum discretion” in applying the reasonable basis standard. See, e.g., Silva v. Sec’y of Health & Hum. Servs., 108 Fed. Cl. 401, 401–02 (Fed. Cl. 2012). 3

As Petitioner correctly notes, the issue of reasonable basis has not been directly raised, or challenged, by Respondent. Interim Fees Mot. at 10–11; Response at 3. Nevertheless, and concurrent with my obligation to award only reasonable fees in any case, it falls to me to evaluate whether reasonable basis exists regardless of whether Respondent addresses the matter (and indeed—just as I can make sua sponte changes to fees despite Respondent’s failure to raise an objection, I am empowered to decide reasonable basis similarly).

In this case, I have some concerns about the claim’s ultimate viability.

Free access — add to your briefcase to read the full text and ask questions with AI

Ayyasolla v. Secretary of Health and Human Services, (uscfc 2022).

Ayyasolla v. Secretary of Health and Human Services (Ayyasolla v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related